SVP, Commercial Strategy

Chief Technical Officer

AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Akero Therapeutics, Inc. - AKRO

Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition

Akero Therapeutics Insider Sold Shares Worth $1,374,665, According to a Recent SEC Filing

Akero Therapeutics Executives Sell Shares to Cover Tax Obligations

Contracts Specialist

Akero Therapeutics is a clinical stage biopharmaceutical company focused on developing treatments for serious metabolic diseases. They are seeking an experienced Contracts Specialist to manage the preparation, review, negotiation, and management of various types of contracts while collaborating with legal and finance departments.

Sign up with Google

Sign in with Google